Holmium-166-DTPA as a liquid source for endovascular brachytherapy

Nuclear Medicine and Biology

Volumn 29, Issue 8, 2002, Pages 833-839

  Hong, Young Don ^a   Park, Kyung Bae ^a   Jang, Beom Su ^b   Choi, Sun Ju ^a   Choi, Sang Moo ^a   Kim, Young Mi ^a  

^a Korea Atomic Energy Research Institute   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

DTPA; Holmium 166; Radiation brachytherapy; Restenosis

Indexed keywords

HOLMIUM; PENTACARBOXYMETHYL DIETHYLENETRIAMINE HO 166; PENTETIC ACID; SILICA GEL; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON; BRACHYTHERAPY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EXCRETION; ENDOVASCULAR BRACHYTHERAPY; IN VIVO STUDY; ISOTOPE LABELING; LIQUID; MALE; NONHUMAN; PH; RADIATION DOSE DISTRIBUTION; RADIOACTIVITY; RADIOCHEMISTRY; RAT; RESTENOSIS; ROOM TEMPERATURE; SCINTILLATION CAMERA; THIN LAYER CHROMATOGRAPHY; URINARY EXCRETION; ANIMAL; CHEMISTRY; INSTRUMENTATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; METHODOLOGY; RABBIT; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOLUTION AND SOLUBILITY; SYNTHESIS; TISSUE DISTRIBUTION; VASCULAR DISEASE; WHOLE BODY COUNTING;

ANIMALS; BRACHYTHERAPY; HOLMIUM; INJECTIONS, INTRAVENOUS; ISOTOPE LABELING; MALE; METABOLIC CLEARANCE RATE; PENTETIC ACID; RABBITS; RADIOISOTOPES; RADIOPHARMACEUTICALS; RATS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLUTIONS; TISSUE DISTRIBUTION; VASCULAR DISEASES; WHOLE-BODY COUNTING;

EID: 0036849548     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(02)00329-3     Document Type: Article

References (22)

1. 166Ho]holmium labeled ethylene dicysteine. Nucl Med Biol. 28:2001;309-317.
2. Gruentzig A.R. Gruentzig answers questions about PTCA, Interview by Purcell and Griffin. Am J Nurs. 81:(9):1981;1624-1626.
3. Gruentzig A.R., Senning A., Siegenthaler W. (1981) Non-operative dilatation of coronary artery stenosis percutaneous transluminal coronary angioplasty. N Engl J Med. 301:1981;61-63.
4. Guhlke S., Beets A.L., Oetjen K., et al. Simple new method for effective concentration of Re solutions from alumina-based W-Re generator. J Nucl Med. 40:(7):2000;1271-1278.
5. Kim H.S., Cho Y.H., Oh Y.T., Park K.B., et al. Effect of transcarthetar endovascular holmium-166 irradiation on neointimal formation after balloon injury in porcine coronary artery. J Am Coll Cardiol. 31:(suppl A):1998;277A.
6. Knapp F.F. Jr, Beets A.L., Guhlke S., et al. A development of the alumina-based W-188/Re-188 generators. Appl Radiat Isot. 45:1994;1123-1128.
7. Knapp F.F. Jr, Beets A.L., Guhlke S. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment. Anticancer Res. 17:1997;1783-1795.
8. Knapp F.F. Jr, Guhlke S., Beets A.L., Amols H., Weinberger J. Intraarterial irradiation with rhenium-188 for inhibition of restenosis after PTCA-strategy and evaluation of species for rapid urinary excretion. [abstract] J Nucl Med. 38:1997;124.
9. Knapp F.F. Jr, Guhlke S., Beets A.L., Lin W.Y., Stabin M., Amols H., Weinberger J. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes pharmacologic and dosimetric properties of rhenium-188 compounds. Cardiovasc Radiat Med. 1:1999;86-97.
10. Lee J., Shin A., Chung J.K., Lee M.M., Lee M.C. Rhenium-188-DTPA liquid-filled balloon to inhibit restenosis after angioplasty development of software of dose calculation and application. J Nucl Med. 40:1999;181.
11. Mabin T.A., Holmes D.R., Smith H.C. Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty. Circ Res. 71:1985;754-760.
12. Majali M.A. Studies on the preparation of Re-188-DTPA complexes using low specific activity Re-186 for antibody labeling. J Radianal Nucl Chem. 170:1993;471.
13. 166Ho-DTPA. Nucl Med Commun. 22:(1):2001;97-103.
14. Popma J.J., Califf R.M., Topol E.J. Clinical trials of restenosis after coronary angioplasty. Circulation. 84:1991;1426-1436.
15. Schwartz R.S., Koval T.M., Edwards W.D., et al. Effects of external beam irradiation on neointimal hyperplasia after experimental coronary artery injury. J Am Coll Cardiol. 19:1992;1106-1113.
16. Serruys P.W., Luitjen H.E., Beatt K.J. Incidence of restenosis after successful coronary angioplasty a time-related phenomena - a quantitative angiographic study in 342 consecutive patients at 1,2,3 and 4 months. Circ Res. 79:1989;1374-1385.
17. Suzuki Y.S., Momose Y., Higashi N., Shigemastu A., Park K.B., Kim Y.M. Biodistribution and kinetics of holmium-166-chitosan complex (DW-166 HC) in rats and mice. J Nucl Med. 39:1998;2161-2166.
18. Thornton M.A., Gruentzig A.R., Hollman J., et al. Coumadin and aspirin in the prevention of recurrence after transluminal coronary angioplasty a randomized study. Circulation. 69:1984;721-727.
19. Volkert A.W., Jurisson S. Technetium-99m chelates as radiopharmaceuticals. Yoshihara K., Omori T., Technetium and Rhenium Their Chemistry and Its Applications. 1996;123-148 Springer-Verlag, Berlin Heidelberg.
20. Waksman R., Robinson K.A., Crocker I.R., et al. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. Circulation. 91:1995;1533-1539.
21. Weinberger J., Knapp F.F. Use of liquid filled balloons for coronary irradiation. Waksman R., Vascular Brachytherapy. 2nd ed. 1992;521-535.
22. Wiederman J.G., Marboe C., Amols H., et al. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in porcine model. J Am Coll Cardiol. 23:1994;1491-1498.